{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:39:31Z","timestamp":1794494371699,"version":"4.9.1"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-025-01044-6","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:37:30Z","timestamp":1764686250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Omega-3 fatty acids and chemotherapy-induced toxicities: mechanisms and emerging evidence with a pediatric focus"],"prefix":"10.1186","volume":"22","author":[{"given":"R.","family":"Maldonado-Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Caballero-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Castillejos-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aquino-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Velasco-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pliego-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Alavez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Montesinos-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Torres-Esp\u00edndola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"1044_CR1","unstructured":"World Health Organization. Cancer [Internet], Geneva WHO. 2020 [cited 2020 Sep 8]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"1044_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112503","volume":"146","author":"J Zeien","year":"2022","unstructured":"Zeien J, Qiu W, Triay M, Dhaibar HA, Cruz-Topete D, Cornett EM, et al. Clinical implications of chemotherapeutic agent organ toxicity on perioperative care. Biomed Pharmacother. 2022;146:112503.","journal-title":"Biomed Pharmacother"},{"key":"1044_CR3","volume-title":"Principles of critical Care, 4e","author":"KE Hale","year":"2015","unstructured":"Hale KE. Toxicities of chemotherapy. In: Hall JB, Schmidt GA, Kress JP, editors. Principles of critical Care, 4e. New York, NY: McGraw-Hill Education; 2015."},{"key":"1044_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072421","volume":"13","author":"I Djuricic","year":"2021","unstructured":"Djuricic I, Calder PC. Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: an update for 2021. Nutrients. 2021;13:7.","journal-title":"Nutrients"},{"issue":"1","key":"1044_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/S0954422416000044","volume":"29","author":"S Serini","year":"2016","unstructured":"Serini S, Ottes Vasconcelos R, Fasano E, Calviello G. How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer? Nutr Res Rev. 2016;29(1):102\u201325.","journal-title":"Nutr Res Rev"},{"key":"1044_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19137936","author":"M Fodil","year":"2022","unstructured":"Fodil M, Blanckaert V, Ulmann L, Mimouni V, Ch\u00e9nais B. Contribution of n-3 long-chain polyunsaturated fatty acids to the prevention of breast cancer risk factors. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph19137936.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1044_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nut.2015.06.010","volume":"32","author":"NS Elbarbary","year":"2016","unstructured":"Elbarbary NS, Ismail EAR, Farahat RK, El-Hamamsy M. \u03c9-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: a randomized placebo-controlled study. Nutrition. 2016;32(1):41\u20137.","journal-title":"Nutrition"},{"key":"1044_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061206","author":"M Newell","year":"2021","unstructured":"Newell M, Mazurak V, Postovit LM, Field CJ. N-3 long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic acid, and the role of supplementation during cancer treatment: a scoping review of current clinical evidence. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13061206.","journal-title":"Cancers (Basel)"},{"key":"1044_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072279","author":"C Giordano","year":"2020","unstructured":"Giordano C, Plastina P, Barone I, Catalano S, Bonofiglio D. N-3 polyunsaturated fatty acid amides: new avenues in the prevention and treatment of breast cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21072279.","journal-title":"Int J Mol Sci"},{"key":"1044_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu11050945","author":"RDS Freitas","year":"2019","unstructured":"Freitas RDS, Campos MM. Protective effects of omega-3 fatty acids in cancer-related complications. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11050945.","journal-title":"Nutrients"},{"key":"1044_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jnim.2016.05.001","volume":"5","author":"SL Morland","year":"2016","unstructured":"Morland SL, Martins KJB, Mazurak VC. N-3 polyunsaturated fatty acid supplementation during cancer chemotherapy. J Nutr Intermed Metab. 2016;5:107\u201316.","journal-title":"J Nutr Intermed Metab"},{"issue":"3","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10555-015-9572-2","volume":"34","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, et al. Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Cancer Metastasis Rev. 2015;34(3):359\u201380.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1534735415610427","volume":"15","author":"A Yasueda","year":"2016","unstructured":"Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther. 2016;15(1):17\u201339.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"1044_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6719534","volume":"2016","author":"N Mut-Salud","year":"2016","unstructured":"Mut-Salud N, \u00c1lvarez PJ, Garrido JM, Carrasco E, Ar\u00e1nega A, Rodr\u00edguez-Serrano F. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results. Oxid Med Cell Longev. 2016;2016(1):6719534.","journal-title":"Oxid Med Cell Longev"},{"key":"1044_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.clnesp.2018.02.006","volume":"25","author":"DS Lavriv","year":"2018","unstructured":"Lavriv DS, Neves PM, Ravasco P. Should omega-3 fatty acids be used for adjuvant treatment of cancer cachexia? Clin Nutr ESPEN. 2018;25:18\u201325.","journal-title":"Clin Nutr ESPEN"},{"key":"1044_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00852","volume":"10","author":"P Ir\u00fan","year":"2019","unstructured":"Ir\u00fan P, Lanas A, Piazuelo E. Omega-3 polyunsaturated fatty acids and their bioactive metabolites in gastrointestinal malignancies related to unresolved inflammation. A review. Front Pharmacol. 2019;10:852.","journal-title":"Front Pharmacol"},{"issue":"25","key":"1044_CR17","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk Factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","volume":"56","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos AP. The importance of the ratio of omega-6\/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365\u201379.","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"1044_CR19","first-page":"7380","volume":"27","author":"R Poggioli","year":"2023","unstructured":"Poggioli R, Hirani K, Jogani VG, Ricordi C. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders. Eur Rev Med Pharmacol Sci. 2023;27(15):7380\u2013400.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1044_CR20","doi-asserted-by":"crossref","unstructured":"Videla LA, Hernandez-Rodas MC, Metherel AH, Valenzuela R. Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease. Prostaglandins, Leukot Essent Fat Acids [Internet]. 2022;181:102441. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0952327822000539","DOI":"10.1016\/j.plefa.2022.102441"},{"key":"1044_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043547","author":"M Monirujjaman","year":"2023","unstructured":"Monirujjaman M, Renani LB, Isesele P, Dunichand-Hoedl AR, Mazurak VC. Increased expression of hepatic Stearoyl-CoA desaturase (SCD)-1 and depletion of eicosapentaenoic acid (EPA) content following cytotoxic cancer therapy are reversed by dietary fish oil. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043547.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1044_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/biof.1992","volume":"50","author":"R Valenzuela","year":"2024","unstructured":"Valenzuela R, Metherel AH, Cisbani G, Smith ME, Chouinard-Watkins R, Klievik BJ, et al. Protein concentrations and activities of fatty acid desaturase and elongase enzymes in liver, brain, testicle, and kidney from mice: substrate dependency. Biofactors. 2024;50(1):89\u2013100. https:\/\/doi.org\/10.1002\/biof.1992.","journal-title":"Biofactors"},{"issue":"20","key":"1044_CR23","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","volume":"58","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047\u201367. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.063.","journal-title":"J Am Coll Cardiol"},{"key":"1044_CR24","doi-asserted-by":"publisher","unstructured":"Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6(6):456\u201364. https:\/\/doi.org\/10.1016\/j.jalz.2010.01.013.","DOI":"10.1016\/j.jalz.2010.01.013"},{"issue":"5","key":"1044_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096905","volume":"9","author":"G Grosso","year":"2014","unstructured":"Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One. 2014;9(5):e96905. https:\/\/doi.org\/10.1371\/journal.pone.0096905.","journal-title":"PLoS One"},{"issue":"4","key":"1044_CR26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","volume":"56","author":"HM Parker","year":"2012","unstructured":"Parker HM, Johnson NA, Burdon CA, Cohn JS, O\u2019Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56(4):944\u201351. https:\/\/doi.org\/10.1016\/j.jhep.2011.08.018.","journal-title":"J Hepatol"},{"issue":"18","key":"1044_CR27","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","volume":"378","author":"PA Asbell","year":"2018","unstructured":"Dry Eye Assessment and Management Study Research Group, Asbell PA, Maguire MG, Pistilli M, Ying GS, Szczotka-Flynn LB, Hardten DR, Lin MC, Shtein RM. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med. 2018;378(18):1681\u201390. https:\/\/doi.org\/10.1056\/NEJMoa1709691.","journal-title":"N Engl J Med"},{"issue":"11","key":"1044_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003402.pub3","volume":"11","author":"P Middleton","year":"2018","unstructured":"Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018;11(11):CD003402. https:\/\/doi.org\/10.1002\/14651858.CD003402.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1044_CR29","doi-asserted-by":"publisher","unstructured":"Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC. International society for the study of fatty acids and Lipids, ISSFAL. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fat Acids 2009 Feb-Mar;80(2\u20133):85\u201391. https:\/\/doi.org\/10.1016\/j.plefa.2009.01.004","DOI":"10.1016\/j.plefa.2009.01.004"},{"issue":"6 Suppl","key":"1044_CR30","doi-asserted-by":"publisher","first-page":"S1526","DOI":"10.1093\/ajcn\/83.6.1526S","volume":"83","author":"SK Gebauer","year":"2006","unstructured":"Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr. 2006;83(6 Suppl):S1526\u201335.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"1044_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/dxz001","volume":"31","author":"T Ishihara","year":"2019","unstructured":"Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019;31(9):559\u201367.","journal-title":"Int Immunol"},{"issue":"1","key":"1044_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/09612033221140724","volume":"32","author":"M Salek","year":"2023","unstructured":"Salek M, Hosseini Hooshiar S, Salek M, Poorebrahimi M, Jafarnejad S. Omega-3 fatty acids: current insights into mechanisms of action in systemic lupus erythematosus. Lupus. 2023;32(1):7\u201322.","journal-title":"Lupus"},{"key":"1044_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102357","author":"MA Karalexi","year":"2022","unstructured":"Karalexi MA, Markozannes G, Tagkas CF, Katsimpris A, Tseretopoulou X, Tsilidis KK, et al. Nutritional status at diagnosis as predictor of survival from childhood cancer: a review of the literature. Diagnostics. 2022. https:\/\/doi.org\/10.3390\/diagnostics12102357.","journal-title":"Diagnostics"},{"key":"1044_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu16091327","author":"A Budka-Chrz\u0119szczyk","year":"2024","unstructured":"Budka-Chrz\u0119szczyk A, Szlagatys-Sidorkiewicz A, Bie\u0144 E, Irga-Jaworska N, Borkowska A, Krawczyk MA, et al. Managing undernutrition in pediatric oncology: a consensus statement developed using the Delphi method by the Polish society for clinical nutrition of children and the Polish society of pediatric oncology and hematology. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16091327.","journal-title":"Nutrients"},{"key":"1044_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061800","author":"A Podpeskar","year":"2021","unstructured":"Podpeskar A, Crazzolara R, Kropshofer G, Hetzer B, Meister B, M\u00fcller T, et al. Omega-3 fatty acids and their role in pediatric cancer. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13061800.","journal-title":"Nutrients"},{"issue":"1","key":"1044_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbe1401004","volume":"14","author":"S Triarico","year":"2022","unstructured":"Triarico S, Rinninella E, Attin\u00e0 G, Romano A, Maurizi P, Mastrangelo S, et al. Nutritional status in the pediatric oncology patients. Front Biosci (Elite Ed). 2022;14(1):4.","journal-title":"Front Biosci (Elite Ed)"},{"key":"1044_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030710","author":"L Pedretti","year":"2023","unstructured":"Pedretti L, Massa S, Leardini D, Muratore E, Rahman S, Pession A, et al. Role of nutrition in pediatric patients with cancer. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15030710.","journal-title":"Nutrients"},{"issue":"2","key":"1044_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/0019-509X.175830","volume":"52","author":"PC Rogers","year":"2015","unstructured":"Rogers PC. Importance of nutrition in pediatric oncology. Indian J Cancer. 2015;52(2):176\u20138.","journal-title":"Indian J Cancer"},{"key":"1044_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103522","author":"G Rovesti","year":"2021","unstructured":"Rovesti G, Valoriani F, Rimini M, Bardasi C, Ballarin R, Di Benedetto F, et al. Clinical implications of malnutrition in the management of patients with pancreatic cancer: introducing the concept of the nutritional oncology board. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13103522.","journal-title":"Nutrients"},{"issue":"4","key":"1044_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/ncp.10919","volume":"38","author":"C Hawes","year":"2023","unstructured":"Hawes C, Gomes A, Byham-Gray L, Henderson S. The effect of oral nutrition supplements and appetite stimulants on weight status among pediatric cancer patients: a systematic review. Nutr Clin Pract. 2023;38(4):761\u201374.","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"1044_CR41","first-page":"113","volume":"76","author":"E Damasco-\u00c1vila","year":"2019","unstructured":"Damasco-\u00c1vila E, Velasco-Hidalgo L, Zapata-Tarr\u00e9s M, C\u00e1rdenas-Cardos R, Rivera-Luna R. Feeding difficulties and eating disorders in pediatric patients with cancer. Bol Med Hosp Infant Mex. 2019;76(3):113\u20139.","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"10","key":"1044_CR42","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1111\/apa.16889","volume":"112","author":"A Grain","year":"2023","unstructured":"Grain A, Camuset M, Gras-Leguen C, Hardouin JB, Scherdel P, Caldari D. Taste and smell alterations affect nutritional status in children under chemotherapy. Acta Paediatr. 2023;112(10):2231\u20138.","journal-title":"Acta Paediatr"},{"issue":"3","key":"1044_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/children11030334","volume":"11","author":"I Kranj\u010dec","year":"2024","unstructured":"Kranj\u010dec I, Pranji\u0107 I, Roganovi\u0107 J, Pavlovi\u0107 M, Raja\u010di\u0107 N, Sila S. Alterations of nutritional status in children and adolescents with acute lymphoblastic leukemia. Children. 2024;11(3):334.","journal-title":"Children"},{"issue":"8","key":"1044_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MPH.0000000000002246","volume":"43","author":"DV Runco","year":"2021","unstructured":"Runco DV, Wasilewski-Masker K, Mazewski CM, Patterson BC, Mertens AC. Features associated with weight loss and growth stunting for young children during cancer therapy. J Pediatr Hematol Oncol. 2021;43(8):301\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1044_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1744-6155.2012.00341.x","volume":"17","author":"PC Tah","year":"2012","unstructured":"Tah PC, Nik Shanita S, Poh BK. Nutritional status among pediatric cancer patients: a comparison between hematological malignancies and solid tumors. J Spec Pediatr Nurs. 2012;17(4):301\u201311.","journal-title":"J Spec Pediatr Nurs"},{"issue":"1","key":"1044_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/03008916221084740","volume":"109","author":"SI Tripodi","year":"2023","unstructured":"Tripodi SI, Bergami E, Panigari A, Caissutti V, Brovia C, De Cicco M, et al. The role of nutrition in children with cancer. Tumori. 2023;109(1):19\u201327.","journal-title":"Tumori"},{"key":"1044_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2021.102285","volume":"169","author":"L Ljungblad","year":"2021","unstructured":"Ljungblad L, Gleissman H, Hedberg G, Wickstr\u00f6m M, Eissler N, Pickova J, et al. Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children. Prostaglandins Leukot Essent Fatty Acids. 2021;169:102285.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1044_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143239","author":"A Podpeskar","year":"2023","unstructured":"Podpeskar A, Crazzolara R, Kropshofer G, Hetzer B, Rabensteiner E, Meister B, et al. Recommendations for nutritional supplementation in pediatric oncology: a compilation of the facts. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15143239.","journal-title":"Nutrients"},{"issue":"5","key":"1044_CR49","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.clnu.2021.03.020","volume":"40","author":"R Revuelta Iniesta","year":"2021","unstructured":"Revuelta Iniesta R, Gerasimidis K, Paciarotti I, McKenzie JM, Brougham MF, Wilson DC. Micronutrient status influences clinical outcomes of paediatric cancer patients during treatment: a prospective cohort study. Clin Nutr. 2021;40(5):2923\u201335.","journal-title":"Clin Nutr"},{"issue":"7","key":"1044_CR50","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.clnu.2022.05.010","volume":"41","author":"S Ganguly","year":"2022","unstructured":"Ganguly S, Srivastava R, Agarwala S, Dwivedi S, Bansal PG, Gonmei Z, et al. Prevalence of micronutrient deficiency and its impact on the outcome of childhood cancer: a prospective cohort study. Clin Nutr. 2022;41(7):1501\u201311.","journal-title":"Clin Nutr"},{"issue":"10","key":"1044_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27895","volume":"66","author":"MBG Morrell","year":"2019","unstructured":"Morrell MBG, Baker R, Johnson A, Santizo R, Liu D, Moody K. Dietary intake and micronutrient deficiency in children with cancer. Pediatr Blood Cancer. 2019;66(10):e27895.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1044_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/07315724.2019.1616233","volume":"39","author":"O Juh\u00e1sz","year":"2020","unstructured":"Juh\u00e1sz O, Jakab Z, Szab\u00f3 A, Garami M. Examining the vitamin D status of children with solid tumors. J Am Coll Nutr. 2020;39(2):128\u201334.","journal-title":"J Am Coll Nutr"},{"issue":"Suppl 3","key":"1044_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28211","volume":"67","author":"K Viani","year":"2020","unstructured":"Viani K, Trehan A, Manzoli B, Schoeman J. Assessment of nutritional status in children with cancer: a narrative review. Pediatr Blood Cancer. 2020;67(Suppl 3):e28211.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1044_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.13273","volume":"38","author":"AL Lovell","year":"2025","unstructured":"Lovell AL, Gardiner B, Henry L, Bate JM, Brougham MFH, Iniesta RR. The evolution of nutritional care in children and young people with acute lymphoblastic leukaemia: a narrative review. J Hum Nutr Diet. 2025;38(1):e13273.","journal-title":"J Hum Nutr Diet"},{"issue":"9","key":"1044_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29104","volume":"68","author":"JH Chung","year":"2021","unstructured":"Chung JH, Phalke N, Hastings C, Killilea DW, Feusner JH, Fung EB. Zinc deficiency and its association with treatment-related toxicity in children with cancer. Pediatr Blood Cancer. 2021;68(9):e29104.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1044_CR56","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/01635581.2017.1324995","volume":"69","author":"YH Chang","year":"2017","unstructured":"Chang YH, Yu MS, Wu KH, Hsu MC, Chiou YH, Wu HP, et al. Effectiveness of parenteral glutamine on Methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Nutr Cancer. 2017;69(5):746\u201351.","journal-title":"Nutr Cancer"},{"issue":"Suppl 3","key":"1044_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28378","volume":"67","author":"A Trehan","year":"2020","unstructured":"Trehan A, Viani K, da Cruz LB, Sagastizado SZ, Ladas EJ. The importance of enteral nutrition to prevent or treat undernutrition in children undergoing treatment for cancer. Pediatr Blood Cancer. 2020;67(Suppl 3):e28378.","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 3","key":"1044_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28213","volume":"67","author":"PC Rogers","year":"2020","unstructured":"Rogers PC, Barr RD. The relevance of nutrition to pediatric oncology: a cancer control perspective. Pediatr Blood Cancer. 2020;67(Suppl 3):e28213.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1044_CR59","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11899-017-0376-z","volume":"12","author":"RR Maxwell","year":"2017","unstructured":"Maxwell RR, Cole PD. Pharmacogenetic predictors of treatment-related toxicity among children with acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2017;12(3):176\u201386.","journal-title":"Curr Hematol Malig Rep"},{"key":"1044_CR60","doi-asserted-by":"publisher","first-page":"e2200580","DOI":"10.1200\/PO.22.00580","volume":"7","author":"T Larkin","year":"2023","unstructured":"Larkin T, Kashif R, Elsayed AH, Greer B, Mangrola K, Rafiee R, et al. Polygenic Pharmacogenomic markers as predictors of toxicity phenotypes in the treatment of acute lymphoblastic leukemia: A Single-Center study. JCO Precis Oncol. 2023;7:e2200580.","journal-title":"JCO Precis Oncol"},{"issue":"11","key":"1044_CR61","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s40262-022-01174-7","volume":"61","author":"G Narendra","year":"2022","unstructured":"Narendra G, Choudhary S, Raju B, Verma H, Silakari O. Role of genetic polymorphisms in drug-metabolizing enzyme-mediated toxicity and pharmacokinetic resistance to anti-cancer agents: a review on the pharmacogenomics aspect. Clin Pharmacokinet. 2022;61(11):1495\u2013517.","journal-title":"Clin Pharmacokinet"},{"key":"1044_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1445328","volume":"15","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Tang M, Deng Z, Cai P. Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review. Front Pharmacol. 2024;15:1445328.","journal-title":"Front Pharmacol"},{"key":"1044_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312808","author":"M Zhao","year":"2021","unstructured":"Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222312808.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1044_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/1354750X.2020.1754913","volume":"25","author":"LM Torres Esp\u00edndola","year":"2020","unstructured":"Torres Esp\u00edndola LM, Rojo-Serrato D, \u00c1lvaro-Heredia A, Castillejos L\u00f3pez M, de U\u00f1a-Flores J, P\u00e9rez-Garc\u00eda A. Analysis of CYP450 gene allelic variants can predict Ifosfamide toxicity in Mexican paediatric patients. Biomarkers. 2020;25(4):331\u201340.","journal-title":"Biomarkers"},{"issue":"10","key":"1044_CR65","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/17425255.2020.1807937","volume":"16","author":"K Petrykey","year":"2020","unstructured":"Petrykey K, Andelfinger GU, Laverdi\u00e8re C, Sinnett D, Krajinovic M. Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer. Expert Opin Drug Metab Toxicol. 2020;16(10):865\u201383.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"14","key":"1044_CR66","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2217\/pgs-2021-0067","volume":"22","author":"K Petrykey","year":"2021","unstructured":"Petrykey K, Rezgui AM, Guern ML, Beaulieu P, St-Onge P, Drouin S, et al. Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics. 2021;22(14):885\u2013901.","journal-title":"Pharmacogenomics"},{"key":"1044_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2020.108324","volume":"786","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Deng Z, Tang M, Xiao D, Cai P. Impact of genetic factors on platinum-induced gastrointestinal toxicity. Mutat Res. 2020;786:108324.","journal-title":"Mutat Res"},{"issue":"4","key":"1044_CR68","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00280-019-03794-6","volume":"83","author":"B De Troia","year":"2019","unstructured":"De Troia B, Dalu D, Filipazzi V, Isabella L, Tosca N, Ferrario S, et al. ABCB1 c.3435C\u2009>\u2009T polymorphism is associated with platinum toxicity: a preliminary study. Cancer Chemother Pharmacol. 2019;83(4):803\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1044_CR69","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/blood-2021-151357","volume":"138","author":"R Kashif","year":"2021","unstructured":"Kashif R, Larkin T, Elsayed AH, Nguyen NHK, Emanuel N, Shastri VM, et al. Pharmacogenomic single nucleotide polymorphism (SNP) variants as predictors of toxicity phenotypes in the treatment of acute childhood leukemia. Blood. 2021;138:3360.","journal-title":"Blood"},{"key":"1044_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.867873","volume":"9","author":"TK Al-Otaibi","year":"2022","unstructured":"Al-Otaibi TK, Weitzman B, Tahir UA, Asnani A. Genetics of anthracycline-associated cardiotoxicity. Front Cardiovasc Med. 2022;9:867873.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"1044_CR71","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12026-022-09307-7","volume":"70","author":"P Gupta","year":"2022","unstructured":"Gupta P, Makkar TK, Goel L, Pahuja M. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity. Immunol Res. 2022;70(6):725\u201341.","journal-title":"Immunol Res"},{"issue":"6","key":"1044_CR72","volume":"13","author":"P Dewan","year":"2021","unstructured":"Dewan P, Chaudhary P, Gomber S, Ahmed RS, Kotru M. Oxidative stress in cerebrospinal fluid during treatment in childhood acute lymphoblastic leukemia. Cureus. 2021;13(6):e15997.","journal-title":"Cureus"},{"issue":"3","key":"1044_CR73","volume":"15","author":"P Chaudhary","year":"2023","unstructured":"Chaudhary P, Kumari S, Dewan P, Gomber S, Ahmed RS, Kotru M. Chemotherapy-induced oxidative stress in pediatric acute lymphoblastic leukemia. Cureus. 2023;15(3):e35968.","journal-title":"Cureus"},{"key":"1044_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","volume":"155","author":"HI Akbarali","year":"2022","unstructured":"Akbarali HI, Muchhala KH, Jessup DK, Cheatham S. Chemotherapy induced Gastrointestinal toxicities. Adv Cancer Res. 2022;155:131\u201366.","journal-title":"Adv Cancer Res"},{"issue":"41","key":"1044_CR75","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.2174\/0929867328666210218110550","volume":"28","author":"A Rizvi","year":"2021","unstructured":"Rizvi A, Farhan M, Nabi F, Khan RH, Adil M, Ahmad A. Transcriptional control of the oxidative stress response and implications of using plant derived molecules for therapeutic interventions in cancer. Curr Med Chem. 2021;28(41):8480\u201395.","journal-title":"Curr Med Chem"},{"key":"1044_CR76","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5478708","volume":"2020","author":"M Gyur\u00e1szov\u00e1","year":"2020","unstructured":"Gyur\u00e1szov\u00e1 M, Gureck\u00e1 R, B\u00e1b\u00ed\u010dkov\u00e1 J, T\u00f3thov\u00e1 \u013d. Oxidative stress in the pathophysiology of kidney disease: implications for noninvasive monitoring and identification of biomarkers. Oxid Med Cell Longev. 2020;2020:5478708.","journal-title":"Oxid Med Cell Longev"},{"issue":"13","key":"1044_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/nu16132044","volume":"16","author":"D Fern\u00e1ndez-L\u00e1zaro","year":"2024","unstructured":"Fern\u00e1ndez-L\u00e1zaro D, Arribalzaga S, Guti\u00e9rrez-Abej\u00f3n E, Azarbayjani MA, Mielgo-Ayuso J, Roche E. Omega-3 fatty acid supplementation on post-exercise inflammation, muscle damage, oxidative response, and sports performance in physically healthy adults-a systematic review of randomized controlled trials. Nutrients. 2024;16(13):2044. https:\/\/doi.org\/10.3390\/nu16132044.","journal-title":"Nutrients"},{"key":"1044_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.681417","volume":"12","author":"D Dahlgren","year":"2021","unstructured":"Dahlgren D, Sj\u00f6blom M, Hellstr\u00f6m PM, Lennern\u00e4s H. Chemotherapeutics-induced intestinal mucositis: pathophysiology and potential treatment strategies. Front Pharmacol. 2021;12:681417.","journal-title":"Front Pharmacol"},{"key":"1044_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00354","volume":"8","author":"M Cinausero","year":"2017","unstructured":"Cinausero M, Aprile G, Ermacora P, Basile D, Vitale MG, Fanotto V, et al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front Pharmacol. 2017;8:354.","journal-title":"Front Pharmacol"},{"key":"1044_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.626687","volume":"11","author":"G Fumagalli","year":"2020","unstructured":"Fumagalli G, Monza L, Cavaletti G, Rigolio R, Meregalli C. Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy. Front Immunol. 2020;11:626687.","journal-title":"Front Immunol"},{"issue":"34","key":"1044_CR81","doi-asserted-by":"publisher","first-page":"23426","DOI":"10.18632\/oncotarget.25193","volume":"9","author":"JJV Branca","year":"2018","unstructured":"Branca JJV, Maresca M, Morucci G, Becatti M, Paternostro F, Gulisano M, et al. Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity. Oncotarget. 2018;9(34):23426\u201338.","journal-title":"Oncotarget"},{"issue":"11","key":"1044_CR82","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3390\/cells9112350","volume":"9","author":"ND Anfinogenova","year":"2020","unstructured":"Anfinogenova ND, Quinn MT, Schepetkin IA, Atochin DN. Alarmins and c-Jun N-Terminal kinase (JNK) signaling in neuroinflammation. Cells. 2020;9(11):2350.","journal-title":"Cells"},{"issue":"1","key":"1044_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78896-w","volume":"10","author":"A Cetinkaya-Fisgin","year":"2020","unstructured":"Cetinkaya-Fisgin A, Luan X, Reed N, Jeong YE, Oh BC, Hoke A. Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation. Sci Rep. 2020;10(1):21889.","journal-title":"Sci Rep"},{"key":"1044_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113141","volume":"325","author":"A Calls","year":"2020","unstructured":"Calls A, Carozzi V, Navarro X, Monza L, Bruna J. Pathogenesis of platinum-induced peripheral neurotoxicity: insights from preclinical studies. Exp Neurol. 2020;325:113141.","journal-title":"Exp Neurol"},{"issue":"2","key":"1044_CR85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","volume":"18","author":"CY Kong","year":"2022","unstructured":"Kong CY, Guo Z, Song P, Zhang X, Yuan YP, Teng T, et al. Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death. Int J Biol Sci. 2022;18(2):760\u201370.","journal-title":"Int J Biol Sci"},{"key":"1044_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106939","volume":"203","author":"EA Elmorsy","year":"2024","unstructured":"Elmorsy EA, Saber S, Hamad RS, Abdel-Reheim MA, El-Kott AF, AlShehri MA, et al. Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies. Eur J Pharm Sci. 2024;203:106939.","journal-title":"Eur J Pharm Sci"},{"key":"1044_CR87","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2017.01.037","volume":"104","author":"L Zhou","year":"2017","unstructured":"Zhou L, Li R, Liu C, Sun T, Htet Aung LH, Chen C, et al. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2. Free Radic Biol Med. 2017;104:360\u201370.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1044_CR88","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MCO.0b013e328351c32f","volume":"15","author":"RA Murphy","year":"2012","unstructured":"Murphy RA, Mourtzakis M, Mazurak VC. N-3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Curr Opin Clin Nutr Metab Care. 2012;15(3):246\u201351. https:\/\/doi.org\/10.1097\/MCO.0b013e328351c32f.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1044_CR89","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1042\/BST20160474","volume":"45","author":"PC Calder","year":"2017","unstructured":"Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105\u201315. https:\/\/doi.org\/10.1042\/BST20160474.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"1044_CR90","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MCO.0b013e32835d2d99","volume":"16","author":"A Laviano","year":"2013","unstructured":"Laviano A, Rianda S, Molfino A, Rossi Fanelli F. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care. 2013;16(2):156\u201361. https:\/\/doi.org\/10.1097\/MCO.0b013e32835d2d99.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1044_CR91","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2021.11.023","volume":"526","author":"L Wei","year":"2022","unstructured":"Wei L, Wu Z, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids-an update. Cancer Lett. 2022;526:193\u2013204.","journal-title":"Cancer Lett"},{"issue":"3","key":"1044_CR92","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/bjc.2012.586","volume":"108","author":"VC Vaughan","year":"2013","unstructured":"Vaughan VC, Hassing MR, Lewandowski PA. Marine polyunsaturated fatty acids and cancer therapy. Br J Cancer. 2013;108(3):486\u201392.","journal-title":"Br J Cancer"},{"issue":"1","key":"1044_CR93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/humrep\/dex335","volume":"33","author":"YH Chiu","year":"2018","unstructured":"Chiu YH, Karmon AE, Gaskins AJ, Arvizu M, Williams PL, Souter I, et al. Serum omega-3 fatty acids and treatment outcomes among women undergoing assisted reproduction. Hum Reprod. 2018;33(1):156\u201365.","journal-title":"Hum Reprod"},{"issue":"1","key":"1044_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(03)00101-4","volume":"126","author":"W Stillwell","year":"2003","unstructured":"Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003;126(1):1\u201327. https:\/\/doi.org\/10.1016\/S0009-3084(03)00101-4.","journal-title":"Chem Phys Lipids"},{"key":"1044_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.131389","volume":"373","author":"B Xiao","year":"2022","unstructured":"Xiao B, Li Y, Lin Y, Lin J, Zhang L, Wu D, et al. Eicosapentaenoic acid (EPA) exhibits antioxidant activity via mitochondrial modulation. Food Chem. 2022;373:131389. https:\/\/doi.org\/10.1016\/j.foodchem.2021.131389.","journal-title":"Food Chem"},{"issue":"1","key":"1044_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1\u201313. https:\/\/doi.org\/10.1042\/BJ20081386.","journal-title":"Biochem J"},{"issue":"7","key":"1044_CR97","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","volume":"1813","author":"RC Scarpulla","year":"2011","unstructured":"Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta. 2011;1813(7):1269\u201378. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.09.019.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1044_CR98","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1\u03b1): transcriptional coactivator and metabolic regulator. Endocr Rev. 2003;24(1):78\u201390. https:\/\/doi.org\/10.1210\/er.2002-0012.","journal-title":"Endocr Rev"},{"key":"1044_CR99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/128_2012_339","volume":"329","author":"TW Kensler","year":"2013","unstructured":"Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, et al. Keap1-Nrf2 signaling: a target for cancer prevention by Sulforaphane. Top Curr Chem. 2013;329:163\u201377. https:\/\/doi.org\/10.1007\/128_2012_339.","journal-title":"Top Curr Chem"},{"key":"1044_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJ. The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders. Annu Rev Physiol. 2016;78:23\u201344. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105045.","journal-title":"Annu Rev Physiol"},{"key":"1044_CR101","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/736837","volume":"2012","author":"VI Lushchak","year":"2012","unstructured":"Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012;2012:736837. https:\/\/doi.org\/10.1155\/2012\/736837.","journal-title":"J Amino Acids"},{"issue":"8","key":"1044_CR102","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/annonc\/mdx158","volume":"28","author":"AD Ricart","year":"2017","unstructured":"Ricart AD. Drug-induced liver injury in oncology. Ann Oncol. 2017;28(8):2013\u201320.","journal-title":"Ann Oncol"},{"key":"1044_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152840","volume":"458","author":"D Ezhilarasan","year":"2021","unstructured":"Ezhilarasan D. Hepatotoxic potentials of methotrexate: understanding the possible toxicological molecular mechanisms. Toxicology. 2021;458:152840.","journal-title":"Toxicology"},{"issue":"12","key":"1044_CR104","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21(12):1471\u201382.","journal-title":"Oncologist"},{"issue":"5","key":"1044_CR105","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40264-025-01514-z","volume":"48","author":"H Singh","year":"2025","unstructured":"Singh H, Kunkle BF, Troia AR, Suvarnakar AM, Waterman AC, Khin Y, et al. Drug induced liver injury: highlights and controversies in the 2023 literature. Drug Saf. 2025;48(5):455\u201388.","journal-title":"Drug Saf"},{"issue":"12","key":"1044_CR106","first-page":"4151","volume":"10","author":"V Chiruvella","year":"2020","unstructured":"Chiruvella V, Annamaraju P, Guddati AK. Management of nephrotoxicity of chemotherapy and targeted agents: 2020. Am J Cancer Res. 2020;10(12):4151\u201364.","journal-title":"Am J Cancer Res"},{"issue":"Pt 6","key":"1044_CR107","doi-asserted-by":"publisher","first-page":"137457","DOI":"10.1016\/j.ijbiomac.2024.137457","volume":"282","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu Y, Feng W, Mao P, Yang J, Zhao Z, et al. Omega-3 polyunsaturated fatty acids protect against cisplatin-induced nephrotoxicity by activating the Nrf2 signaling pathway. Int J Biol Macromol. 2024;282(Pt 6):137457.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"1044_CR108","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","volume":"22","author":"DJ Crona","year":"2017","unstructured":"Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI. A systematic review of strategies to prevent cisplatin-induced nephrotoxicity. Oncologist. 2017;22(5):609\u201319.","journal-title":"Oncologist"},{"key":"1044_CR109","unstructured":"Francisco \u00c1L. Efectos renales adversos del tratamiento del c\u00e1ncer. In: Lorenzo V, L\u00f3pez-G\u00f3mez JM, editors. Nefrolog\u00eda al d\u00eda [Internet]. Madrid: Sociedad Espa\u00f1ola de Nefrolog\u00eda; 2025 [cited 2025 june 1]. Available from: https:\/\/www.nefrologiaaldia.org\/402"},{"issue":"7","key":"1044_CR110","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.recesp.2016.12.032","volume":"70","author":"R Madonna","year":"2017","unstructured":"Madonna R. Diagn\u00f3stico y prevenci\u00f3n de La cardiotoxicidad inducida Por f\u00e1rmacos antineopl\u00e1sicos: de La imagen a Las tecnolog\u00edas \u00ab\u00f3micas\u00bb. Rev Esp Cardiol. 2017;70(7):576\u201382.","journal-title":"Rev Esp Cardiol"},{"issue":"5","key":"1044_CR111","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","volume":"130","author":"A Dolci","year":"2008","unstructured":"Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol. 2008;130(5):688\u201395.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"1044_CR112","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","volume":"1863","author":"A Ghigo","year":"2016","unstructured":"Ghigo A, Li M, Hirsch E. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochim Biophys Acta. 2016;1863(7):1916\u201325.","journal-title":"Biochim Biophys Acta"},{"key":"1044_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00035","volume":"7","author":"A Murabito","year":"2020","unstructured":"Murabito A, Hirsch E, Ghigo A. Mechanisms of anthracycline-induced cardiotoxicity: is mitochondrial dysfunction the answer? Front Cardiovasc Med. 2020;7:35.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1044_CR114","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00395-024-01078-6","volume":"120","author":"A Moreno-Arciniegas","year":"2025","unstructured":"Moreno-Arciniegas A, C\u00e1diz L, Gal\u00e1n-Arriola C, Clemente-Morag\u00f3n A, Ib\u00e1\u00f1ez B. Cardioprotection strategies for anthracycline cardiotoxicity. Basic Res Cardiol. 2025;120(1):71\u201390.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"1044_CR115","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.advms.2020.04.001","volume":"65","author":"C Pellacani","year":"2020","unstructured":"Pellacani C, Eleftheriou G. Neurotoxicity of antineoplastic drugs: mechanisms, susceptibility, and neuroprotective strategies. Adv Med Sci. 2020;65(2):265\u201385.","journal-title":"Adv Med Sci"},{"issue":"10","key":"1044_CR116","volume":"32","author":"S Fischer","year":"2024","unstructured":"Fischer S, von Bonin M, Bornh\u00e4user M, Beste C, Ziemssen T. Neurological complications in oncology and their monitoring and management in clinical practice: a narrative review. Support Care Cancer. 2024;32(10):685.","journal-title":"Support Care Cancer"},{"key":"1044_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100420","volume":"28","author":"EML Smith","year":"2021","unstructured":"Smith EML, Kuisell C, Cho Y, Kanzawa-Lee GA, Gilchrist LS, Park SB, et al. Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: a systematic review. Cancer Treatment and Research Communications. 2021;28:100420.","journal-title":"Cancer Treatment and Research Communications"},{"issue":"1","key":"1044_CR118","first-page":"18","volume":"70","author":"AJM Beijers","year":"2012","unstructured":"Beijers AJM, Jongen JLM, Vreugdenhil G. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med. 2012;70(1):18\u201325.","journal-title":"Neth J Med"},{"key":"1044_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.750507","volume":"13","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, et al. Mechanisms of chemotherapy-induced neurotoxicity. Front Pharmacol. 2022;13:750507.","journal-title":"Front Pharmacol"},{"key":"1044_CR120","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-G\u00f3mez L, Abalo R, Vera G. Central Neurotoxicity of Chemotherapy. In: Rezaei N, editor. Handbook of Cancer and Immunology [Internet]. Cham: Springer International Publishing; 2022. pp. 1\u201327. Available from: https:\/\/doi.org\/10.1007\/978-3-030-80962-1_345-1","DOI":"10.1007\/978-3-030-80962-1_345-1"},{"issue":"7","key":"1044_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2022.103308","volume":"29","author":"DO Saleh","year":"2022","unstructured":"Saleh DO, Mahmoud SS, Hassan A, Sanad EF. Doxorubicin-induced hepatic toxicity in rats: mechanistic protective role of Omega-3 fatty acids through Nrf2\/HO-1 activation and PI3K\/Akt\/GSK-3\u03b2 axis modulation. Saudi J Biol Sci. 2022;29(7):103308.","journal-title":"Saudi J Biol Sci"},{"key":"1044_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122345","author":"V Ngo","year":"2022","unstructured":"Ngo V, Duennwald ML. Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11122345.","journal-title":"Antioxidants"},{"key":"1044_CR123","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","volume":"17","author":"A Raghunath","year":"2018","unstructured":"Raghunath A, Sundarraj K, Nagarajan R, Arfuso F, Bian J, Kumar AP, et al. Antioxidant response elements: discovery, classes, regulation and potential applications. Redox Biol. 2018;17:297\u2013314.","journal-title":"Redox Biol"},{"key":"1044_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2025.104968","volume":"159","author":"D Rao","year":"2025","unstructured":"Rao D, Wu S. Food oxylipins: formation, distribution, analysis and implications for health. Trends Food Sci Technol. 2025;159:104968.","journal-title":"Trends Food Sci Technol"},{"key":"1044_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225703","author":"M Monirujjaman","year":"2022","unstructured":"Monirujjaman M, Bathe OF, Mazurak VC. Dietary EPA\u2009+\u2009DHA mitigate hepatic toxicity and modify the oxylipin profile in an animal model of colorectal cancer treated with chemotherapy. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14225703.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"1044_CR126","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0748233713483203","volume":"31","author":"F Tulubas","year":"2015","unstructured":"Tulubas F, Gurel A, Oran M, Topcu B, Caglar V, Uygur E. The protective effects of \u03c9-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats. Toxicol Ind Health. 2015;31(7):638\u201344.","journal-title":"Toxicol Ind Health"},{"key":"1044_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.785790","volume":"12","author":"MS Beni\u0107","year":"2021","unstructured":"Beni\u0107 MS, Ne\u017ei\u0107 L, Vuji\u0107-Aleksi\u0107 V, Mititelu-Tartau L. Novel therapies for the treatment of drug-induced liver injury: a systematic review. Front Pharmacol. 2021;12:785790.","journal-title":"Front Pharmacol"},{"issue":"19","key":"1044_CR128","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1039\/D1FO02000E","volume":"12","author":"HH Shi","year":"2021","unstructured":"Shi HH, Chen LP, Wang CC, Zhao YC, Xue CH, Wang YM, et al. Short-term supplementation of DHA-enriched phospholipids attenuates the nephrotoxicity of cisplatin without compromising its antitumor activity in mice. Food Funct. 2021;12(19):9391\u2013404.","journal-title":"Food Funct"},{"key":"1044_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020347","author":"M Fontecha-Barriuso","year":"2020","unstructured":"Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Monsalve M, Ramos AM, Sanchez-Ni\u00f1o MD, et al. The role of PGC-1\u03b1 and mitochondrial biogenesis in kidney diseases. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10020347.","journal-title":"Biomolecules"},{"issue":"12","key":"1044_CR130","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.25122\/jml-2023-0078","volume":"16","author":"SK Abd Alhusen","year":"2023","unstructured":"Abd Alhusen SK, Hasan AF. Evaluating the renoprotective effects of omega-3-6-9 against cisplatin-induced nephrotoxicity in mice. J Med Life. 2023;16(12):1756\u20139.","journal-title":"J Med Life"},{"issue":"7","key":"1044_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29496","volume":"69","author":"D El Amrousy","year":"2022","unstructured":"El Amrousy D, El-Afify D, Khedr R, Ibrahim AM. Omega 3 fatty acids can reduce early doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2022;69(7):e29496.","journal-title":"Pediatr Blood Cancer"},{"key":"1044_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","volume":"307","author":"M Songbo","year":"2019","unstructured":"Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett. 2019;307:41\u20138.","journal-title":"Toxicol Lett"},{"issue":"4","key":"1044_CR133","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1074\/jbc.M607622200","volume":"282","author":"L Gao","year":"2007","unstructured":"Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem. 2007;282(4):2529\u201337.","journal-title":"J Biol Chem"},{"issue":"4","key":"1044_CR134","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0960327113493304","volume":"33","author":"R Uygur","year":"2014","unstructured":"Uygur R, Aktas C, Tulubas F, Alpsoy S, Topcu B, Ozen OA. Cardioprotective effects of fish omega-3 fatty acids on doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol. 2014;33(4):435\u201345.","journal-title":"Hum Exp Toxicol"},{"issue":"11","key":"1044_CR135","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.1002\/fsn3.4492","volume":"12","author":"MG Monte","year":"2024","unstructured":"Monte MG, Tonon CR, Fujimori AS, Ribeiro APD, Zanati SG, Okoshi K, et al. Omega-3 supplementation attenuates doxorubicin-induced cardiotoxicity but is not related to the ceramide pathway. Food Sci Nutr. 2024;12(11):9198\u2013211.","journal-title":"Food Sci Nutr"},{"issue":"10","key":"1044_CR136","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/abbs\/gmt082","volume":"45","author":"X Yu","year":"2013","unstructured":"Yu X, Cui L, Zhang Z, Zhao Q, Li S. \u0391-linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis. Acta Biochim Biophys Sin (Shanghai). 2013;45(10):817\u201326.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"11","key":"1044_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242175","volume":"15","author":"D Saleh","year":"2020","unstructured":"Saleh D, Abdelbaset M, Hassan A, Sharaf O, Mahmoud S, Hegazy R. Omega-3 fatty acids ameliorate doxorubicin-induced cardiorenal toxicity: in-vivo regulation of oxidative stress, apoptosis and renal Nox4, and in-vitro preservation of the cytotoxic efficacy. PLoS One. 2020;15(11):e0242175.","journal-title":"PLoS One"},{"issue":"1","key":"1044_CR138","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12929-014-0101-3","volume":"21","author":"HC Hsu","year":"2014","unstructured":"Hsu HC, Chen CY, Chen MF. N-3 polyunsaturated fatty acids decrease levels of doxorubicin-induced reactive oxygen species in cardiomyocytes \u2013 involvement of uncoupling protein UCP2. J Biomed Sci. 2014;21(1):101.","journal-title":"J Biomed Sci"},{"key":"1044_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.933704","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Xiong JY, Chai YQ, Huang L, Tang ZY, Zhang XF, et al. Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. Front Psychiatry. 2022;13:933704.","journal-title":"Front Psychiatry"},{"issue":"11","key":"1044_CR140","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1089\/ars.2010.3216","volume":"13","author":"N Wakabayashi","year":"2010","unstructured":"Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW. When NRF2 talks, who\u2019s listening? Antioxid Redox Signal. 2010;13(11):1649\u201363.","journal-title":"Antioxid Redox Signal"},{"issue":"Pt 2","key":"1044_CR141","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.freeradbiomed.2022.11.017","volume":"193","author":"S Davinelli","year":"2022","unstructured":"Davinelli S, Medoro A, Intrieri M, Saso L, Scapagnini G, Kang JX. Targeting NRF2-KEAP1 axis by omega-3 fatty acids and their derivatives: emerging opportunities against aging and diseases. Free Radic Biol Med. 2022;193(Pt 2):736\u201350.","journal-title":"Free Radic Biol Med"},{"key":"1044_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12090782","author":"A Angelotti","year":"2022","unstructured":"Angelotti A, Snoke DB, Ormiston K, Cole RM, Borkowski K, Newman JW, et al. Potential cardioprotective effects and lipid mediator differences in long-chain omega-3 polyunsaturated fatty acid supplemented mice given chemotherapy. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12090782.","journal-title":"Metabolites"},{"issue":"1","key":"1044_CR143","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0148607115581838","volume":"40","author":"H Xue","year":"2016","unstructured":"Xue H, Ren W, Denkinger M, Schlotzer E, Wischmeyer PE. Nutrition modulation of cardiotoxicity and anticancer efficacy related to doxorubicin chemotherapy by glutamine and \u03c9-3 polyunsaturated fatty acids. JPEN J Parenter Enteral Nutr. 2016;40(1):52\u201366.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"22","key":"1044_CR144","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.7150\/thno.45924","volume":"10","author":"K Li","year":"2020","unstructured":"Li K, Wang F, Yang ZN, Cui B, Li PP, Li ZY, et al. PML-RAR\u03b1 interaction with TRIB3 impedes PPAR\u03b3\/RXR function and triggers dyslipidemia in acute promyelocytic leukemia. Theranostics. 2020;10(22):10326\u201340.","journal-title":"Theranostics"},{"issue":"4","key":"1044_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231209","volume":"15","author":"PR Mogensen","year":"2020","unstructured":"Mogensen PR, Grell K, Schmiegelow K, Overgaard UM, Wolthers BO, Mogensen SS, et al. Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia. PLoS One. 2020;15(4):e0231209.","journal-title":"PLoS One"},{"issue":"1","key":"1044_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78493-x","volume":"10","author":"S Morel","year":"2020","unstructured":"Morel S, L\u00e9veill\u00e9 P, Samoilenko M, Franco A, England J, Malaquin N, et al. Biomarkers of cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia. Sci Rep. 2020;10(1):21507.","journal-title":"Sci Rep"},{"key":"1044_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1120364","volume":"14","author":"L Barbosa-Cortes","year":"2023","unstructured":"Barbosa-Cortes L, Atilano-Miguel S, Martin-Trejo JA, Jim\u00e9nez-Aguayo E, Mart\u00ednez-Becerril FI, L\u00f3pez-Alarc\u00f3n M, et al. Effect of long-chain omega-3 polyunsaturated fatty acids on cardiometabolic factors in children with acute lymphoblastic leukemia undergoing treatment: a secondary analysis of a randomized controlled trial. Front Endocrinol (Lausanne). 2023;14:1120364.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1044_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122689","author":"S Serini","year":"2017","unstructured":"Serini S, Ottes Vasconcelos R, Nascimento Gomes R, Calviello G. Protective effects of \u03c9-3 PUFA in anthracycline-induced cardiotoxicity: a critical review. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18122689.","journal-title":"Int J Mol Sci"},{"key":"1044_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110384","volume":"271","author":"J Melato","year":"2025","unstructured":"Melato J, Goldoni FC, Benvenutti L, Corr\u00eaa TP, Remor AP, Varela KG, et al. Omega-3-enriched fish oil reduces the chemotherapy-induced peripheral neuropathy in mice. Neuropharmacology. 2025;271:110384.","journal-title":"Neuropharmacology"},{"issue":"4","key":"1044_CR150","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s13311-021-01142-2","volume":"18","author":"EH Bae","year":"2021","unstructured":"Bae EH, Greenwald MK, Schwartz AG. Chemotherapy-induced peripheral neuropathy: mechanisms and therapeutic avenues. Neurotherapeutics. 2021;18(4):2384\u201396.","journal-title":"Neurotherapeutics"},{"key":"1044_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-355","volume":"12","author":"Z Ghoreishi","year":"2012","unstructured":"Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H, et al. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer. 2012;12:355.","journal-title":"BMC Cancer"},{"issue":"50","key":"1044_CR152","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023564","volume":"99","author":"X Zhang","year":"2020","unstructured":"Zhang X, Chen H, Lu Y, Xu C, Yao W, Xu L, et al. Prevention of oxaliplatin-related neurotoxicity by \u03c9-3 pufas: a double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer. Medicine (Baltimore). 2020;99(50):e23564.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1044_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11856-z","volume":"24","author":"NL Gehr","year":"2024","unstructured":"Gehr NL, Karlsson P, Timm S, Christensen S, Hvid CA, Peric J, et al. Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients\u2014a randomized controlled trial (OxaNeuro). BMC Cancer. 2024;24(1):168.","journal-title":"BMC Cancer"},{"issue":"4","key":"1044_CR154","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1177\/1534735418803758","volume":"17","author":"M Maschio","year":"2018","unstructured":"Maschio M, Zarabla A, Maialetti A, Marchesi F, Giannarelli D, Gumenyuk S, et al. Prevention of bortezomib-related peripheral neuropathy with docosahexaenoic acid and \u03b1-lipoic acid in patients with multiple myeloma: preliminary data. Integr Cancer Ther. 2018;17(4):1115\u201324.","journal-title":"Integr Cancer Ther"},{"issue":"15suppl","key":"1044_CR155","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.1039","volume":"32","author":"A Esfahani","year":"2014","unstructured":"Esfahani A, Ghoreishi Z, et al. The effects of omega-3 fatty acids on chemotherapy-induced neuropathy and inflammation in patients with breast cancer. J Clin Oncol. 2014;32(15suppl):1039.","journal-title":"J Clin Oncol"},{"issue":"28","key":"1044_CR156","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, et al. Prevention and management of Chemotherapy-Induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(28):3325\u201348.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"1044_CR157","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1139\/cjpp-2014-0353","volume":"93","author":"L Rochette","year":"2015","unstructured":"Rochette L, Ghibu S, Muresan A, Vergely C. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 2015;93(12):1021\u20137. https:\/\/doi.org\/10.1139\/cjpp-2014-0353.","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"1044_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00667-5","volume":"10","author":"PG Patted","year":"2024","unstructured":"Patted PG, Masareddy RS, Patil AS, Kanabargi RR, Bhat CT. Omega-3 fatty acids: a comprehensive scientific review of their sources, functions and health benefits. Future J Pharm Sci. 2024;10(1):94.","journal-title":"Future J Pharm Sci"},{"key":"1044_CR159","unstructured":"National Institutes of Health, Office of Dietary Supplements. Omega-3 fatty acids\u2014health professional fact sheet [Internet]. Bethesda (MD): NIH; [cited 2025 Jun 1]. Available from: https:\/\/ods.od.nih.gov\/factsheets\/Omega3FattyAcids-HealthProfessional\/"},{"key":"1044_CR160","doi-asserted-by":"crossref","unstructured":"Van der Wurff ISM, Meyer BJ, de Groot RHM. Effect of Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) supplementation on cognition in children and adolescents: A systematic literature review with a focus on n-3 LCPUFA blood values and dose of DHA and EPA. Nutrients. 2020;12(10).","DOI":"10.3390\/nu12103115"},{"issue":"5","key":"1044_CR161","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.athoracsur.2018.01.041","volume":"105","author":"JA Carr","year":"2018","unstructured":"Carr JA. Role of fish oil in post-cardiotomy bleeding: a summary of the basic science and clinical trials. Ann Thorac Surg. 2018;105(5):1563\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"1044_CR162","doi-asserted-by":"publisher","DOI":"10.4081\/ni.2015.5809","volume":"7","author":"P Li","year":"2015","unstructured":"Li P, Kamal H, Baxter M, Mehta BK. Omega-3 fatty acid ethyl esters do not improve clopidogrel associated P2Y12 inhibition in stroke patients. Neurol Int. 2015;7(1):5809.","journal-title":"Neurol Int"},{"issue":"4","key":"1044_CR163","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/ajcn\/nqab013","volume":"113","author":"AD Smith","year":"2021","unstructured":"Smith AD, Jerner\u00e9n F, Refsum H. \u03c9-3 fatty acids and their interactions. Am J Clin Nutr. 2021;113(4):775\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"1044_CR164","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1017\/S000711451300425X","volume":"111","author":"JK Wachira","year":"2014","unstructured":"Wachira JK, Larson MK, Harris WS. N-3 fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights. Br J Nutr. 2014;111(9):1652\u201362.","journal-title":"Br J Nutr"},{"issue":"16","key":"1044_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612623","volume":"24","author":"W Torres","year":"2023","unstructured":"Torres W, P\u00e9rez JL, D\u00edaz MP, D\u2019Marco L, Checa-Ros A, Carrasquero R, et al. The role of specialized pro-resolving lipid mediators in inflammation-induced carcinogenesis. Int J Mol Sci. 2023;24(16):12623. https:\/\/doi.org\/10.3390\/ijms241612623.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1044_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040871","volume":"15","author":"S Jannas-Vela","year":"2023","unstructured":"Jannas-Vela S, Espinosa A, Candia AA, Flores-Opazo M, Pe\u00f1ailillo L, Valenzuela R. The role of omega-3 polyunsaturated fatty acids and their lipid mediators on skeletal muscle regeneration: a narrative review. Nutrients. 2023;15(4):871. https:\/\/doi.org\/10.3390\/nu15040871.","journal-title":"Nutrients"},{"issue":"3","key":"1044_CR167","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/14737175.2024.2313547","volume":"24","author":"N Castellanos-Perilla","year":"2024","unstructured":"Castellanos-Perilla N, Borda MG, Aarsland D, Barreto GE. An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention. Expert Rev Neurother. 2024;24(3):313\u201324.","journal-title":"Expert Rev Neurother"},{"key":"1044_CR168","doi-asserted-by":"crossref","unstructured":"Ciesielski TH. Global access to uncontaminated Omega-3 polyunsaturated fatty acids requires Attention. Vol. 4, AJPM focus. United States; 2025. p. 100341.","DOI":"10.1016\/j.focus.2025.100341"},{"key":"1044_CR169","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.prostaglandins.2015.02.001","volume":"116\u2013117","author":"AC Skulas-Ray","year":"2015","unstructured":"Skulas-Ray AC. Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research. Prostaglandins Other Lipid Mediat. 2015;116\u2013117:104\u201311.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"1044_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051967","volume":"26","author":"Z Frost","year":"2025","unstructured":"Frost Z, Bakhit S, Amaefuna CN, Powers RV, Ramana KV. Recent advances on the role of B vitamins in cancer prevention and progression. Int J Mol Sci. 2025;26(5):1967. https:\/\/doi.org\/10.3390\/ijms26051967.","journal-title":"Int J Mol Sci"},{"key":"1044_CR171","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5414\/CP203602","volume":"58","author":"Y Iimura","year":"2020","unstructured":"Iimura Y, Kurokawa T, Nojima M, Kanemoto Y, Yazawa K, Tsurita G, et al. Potential thiamine deficiency and neurological symptoms in patients receiving chemotherapy for gastrointestinal cancer. Int J Clin Pharmacol Ther. 2020;58:139\u201345. https:\/\/doi.org\/10.5414\/CP203602.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1044_CR172","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1055\/s-0041-1735825","volume":"12","author":"Y Iimura","year":"2021","unstructured":"Iimura Y, Andoh S, Kawamata T, Sato A, Yokoyama K, Imai Y, et al. Thiamine deficiency and neurological symptoms in patients with hematological cancer receiving chemotherapy: a retrospective analysis. J Neurosci Rural Pract. 2021;12:726\u201332. https:\/\/doi.org\/10.1055\/s-0041-1735825.","journal-title":"J Neurosci Rural Pract"},{"issue":"1","key":"1044_CR173","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000462","volume":"3","author":"L Renting","year":"2024","unstructured":"Renting L, Zwart NRK, Ueland PM, McCann A, Ulvik A, van Halteren HK, et al. Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy. BMJ Oncol. 2024;3(1):e000462. https:\/\/doi.org\/10.1136\/bmjonc-2024-000462.","journal-title":"BMJ Oncol"},{"issue":"1\u20132","key":"1044_CR174","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cbi.2006.05.010","volume":"163","author":"F Depeint","year":"2006","unstructured":"Depeint F, Bruce WR, Shangari N, Mehta R, O\u2019Brien PJ. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact. 2006;163(1\u20132):113\u201332. https:\/\/doi.org\/10.1016\/j.cbi.2006.05.010.","journal-title":"Chem Biol Interact"},{"key":"1044_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00078","volume":"10","author":"JJE Janssen","year":"2019","unstructured":"Janssen JJE, Grefte S, Keijer J, de Boer VCJ. Mito-nuclear communication by mitochondrial metabolites and its regulation by B-vitamins. Front Physiol. 2019;10:78. https:\/\/doi.org\/10.3389\/fphys.2019.00078.","journal-title":"Front Physiol"},{"issue":"1","key":"1044_CR176","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3892\/mmr.2016.5270","volume":"14","author":"X Ren","year":"2016","unstructured":"Ren X, Sun H, Zhang C, Li C, Wang J, Shen J, et al. Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p-ERK1\/2\/NRF2\/Trx\/ASK1 signalling pathway in diabetic mice. Mol Med Rep. 2016;14(1):420\u20134. https:\/\/doi.org\/10.3892\/mmr.2016.5270.","journal-title":"Mol Med Rep"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01044-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-025-01044-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01044-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:02:02Z","timestamp":1764691322000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-025-01044-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":176,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1186\/s12986-025-01044-6","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"150"}}